McHale Duncan
Chief Medical Officer at Evelo Biosciences, Inc.
- Sold, on record
- $45k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 8, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Evelo Biosciences, Inc.Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Evelo Biosciences, Inc.RoutineMay 8, 2023 2023
Sold 66,730 shares at $0.13 ($9k)
McHale Duncan, Chief Medical Officer
10b5-1 planSold 40.6% of holdings ($21k position)97,516 shares leftFirst sale on recordFiling
- 2 Form 4 sale Evelo Biosciences, Inc.RoutineAug 8, 2023 +92 days
Sold 3,434 shares at $9.51 ($33k)
McHale Duncan, Chief Medical Officer
10b5-1 planSold 30.2% of holdings ($108k position)7,941 shares leftFiling
- 3 Form 4 sale Evelo Biosciences, Inc.RoutineNov 2, 2023 +86 days
Sold 6,854 shares at $0.33 ($2k)
McHale Duncan, Chief Medical Officer
10b5-1 planSold 33.5% of holdings ($7k position)13,587 shares leftFiling
- 4 Form 4 sale Evelo Biosciences, Inc.RoutineNov 8, 2023 +6 days
Sold 3,103 shares at $0.33 ($1k)
McHale Duncan, Chief Medical Officer
10b5-1 planSold 15.4% of holdings ($7k position)16,984 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Nov 8, 2023 | Evelo Biosciences, Inc. | Chief Medical Officer | Form 4 sale | 3,103 | $1k | 15.4% | Routine | SEC |
| Nov 2, 2023 | Nov 3, 2023 | Evelo Biosciences, Inc. | Chief Medical Officer | Form 4 sale | 6,854 | $2k | 33.5% | Routine | SEC |
| Aug 8, 2023 | Aug 9, 2023 | Evelo Biosciences, Inc. | Chief Medical Officer | Form 4 sale | 3,434 | $33k | 30.2% | Routine | SEC |
| May 8, 2023 | May 10, 2023 | Evelo Biosciences, Inc. | Chief Medical Officer | Form 4 sale | 66,730 | $9k | 40.6% | Routine | SEC |